Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study of Combination Therapy With Radium-223 and Enzalutamide in Osaka City University

NCT03305224 is registered in ClinicalTrials.gov with Taro Iguchi, MD, PHD as lead sponsor.

NCT NCT03305224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03305224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study of Combination Therapy With Radium-223 and Enzalutamide in Osaka City University
Lead sponsor
Taro Iguchi, MD, PHD
Phase
Phase 2
Overall status
Unknown status
Start date
October 27, 2017
Completion date
March 31, 2022
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, castration-resistant prostate cancer